NASDAQ OMX

Sustainalytics Launches ESG Signals

Del

AMSTERDAM, Netherlands, 2016-12-14 10:00 CET (GLOBE NEWSWIRE) --

Sustainalytics, a leading global provider of ESG and corporate governance research and ratings, today launched ESG Signals, an innovative quantitative tool that provides securities-level financial risk and opportunity signals based on environmental, social and governance (ESG), trading and financial data. ESG Signals analyzes thousands of correlations between variables over time and applies machine learning to extract meaningfully predictive risk/opportunity signals.

Sustainalytics developed ESG Signals in collaboration with Advestis, a FinTech company that specializes in machine learning and big data techniques for asset management firms. ESG Signals combines seven years of Sustainalytics’ ESG research on more than 1,600 companies with trading and financial data from Advestis to provide heads of research and portfolio managers with a portfolio monitoring, alerting and investment decision support tool.  In addition, asset managers and index providers can use ESG Signals to develop new products.

For every portfolio security, ESG Signals delivers either an opportunity, neutral or risk signal output. To test the findings, Sustainalytics and Advestis applied ESG Signals to a large cap, market weighted index. The index was adjusted to apply three ESG strategies: normative exclusion, best-in-class selection and a combination of the two. The reweighted indices outperformed the benchmark between 110 and 430 basis points annually, depending on the frequency of rebalancing adopted.

“For almost 25 years, Sustainalytics has been at the forefront of supporting ESG-related investment strategies,” said Sustainalytics’ President and Chief Operating Officer, Bob Mann. “ESG Signals further underscores our commitment to innovation by exploiting big data techniques, quantitative modeling and machine learning to examine the links between ESG and financial performance factors. Our goal is to help investment managers identify and leverage ESG indicators with the most meaningful predictive value.”

To date, ESG integration strategies have been largely qualitative in nature, primarily implemented as part of a qualitative process for risk mitigation.  As ESG factors become increasingly important considerations among mainstream investors, asset managers are looking for investment tools that have the ability to consistently and algorithmically analyze performance-based correlations to identify the most influent variables and in what circumstances they are most influent.

“ESG variables provide additional information not fully captured by today’s financial or trading variables,” said Advestis’ CEO Christoph Geissler. “Leveraging Sustainalytics’ high quality research and extensive ESG experience provides investors with a more comprehensive picture of a portfolio company’s risks and opportunities. We are glad to be partnering with  Sustainalytics to develop ESG Signals and applaud them for their commitment to product innovation.”

For more information on ESG Signals, please visit here.

About Sustainalytics
Sustainalytics is an independent ESG and corporate governance research, ratings and analysis firm supporting investors around the world with the development and implementation of responsible investment strategies. With 14 offices globally, Sustainalytics partners with institutional investors who integrate environmental, social and governance information and assessments into their investment processes. Today, the firm has more than 300 staff members, including 170 analysts with varied multidisciplinary expertise of more than 40 sectors. Through the IRRI survey, investors selected Sustainalytics as the best independent responsible investment research firm for three consecutive years, 2012 through 2014 and in 2015, Sustainalytics was named among the top three firms for both ESG and Corporate Governance research.  For more information, visit www.sustainalytics.com.

About Advestis
Advestis is a Paris-based FinTech that specializes in machine learning and big data techniques for asset management firms. Founded in 2011 by Christopher Geissler, Advestis employs four full-time professionals and is backed by three senior members of its Scientific Advisory board. Geissler is a financial data scientist with more than 30 years of experience in quantitative finance and machine learning. The firm invests more than 75 percent of its revenues in research and development, and has been awarded the ‘Innovating Fintech’ label by Finance Innovation for its work with Sustainalytics on ESG Signals. Advestis’ capital is owned primarily by the founder, members of its Scientific Board, and Quinten, a Paris-based data science company operating primarily in the healthcare and insurance sectors. For more information, visit www.advestis.com/en/.

Disclaimer
Nothing contained in this press release and tool shall be construed as to make a representation or warranty, express or implied, regarding the advisability to invest in or include companies in investable universes and/or portfolios. The performance represented is historical; past performance is not a reliable indicator of future results and results and the information provided in this press release and tool is not intended to be relied upon as, nor to be a substitute for specific professional advice and in particular financial advice. The information is provided “as is” and, therefore Sustainalytics assumes no responsibility for errors or omissions. Sustainalytics accepts no liability for damage arising from the use of press release, tool or information contained herein in any manner whatsoever.

         Media Contacts:
         
         Sarah Cohn, Director of Marketing
         sarah.cohn@sustainalytics.com
         P) +1 646.963.6944
         
         Werner Schoeman, Marketing Manager
         werner.schoeman@sustainalytics.com
         P) +31 20 205 0048

Om NASDAQ OMX

NASDAQ OMX
NASDAQ OMX
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ OMX (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra NASDAQ OMX

Registrer deg med din epostadresse under for å få de nyeste sakene fra NASDAQ OMX på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra NASDAQ OMX

Barings Supports New Mountain Capital Investment in DRB Systems17.10.2017 16:30Pressemelding

CHARLOTTE, N.C., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Barings, one of the world's leading asset management firms, announced today that it served as a Joint Lead Arranger on a Senior Secured Credit Facility to support New Mountain Capital's acquisition of DRB Systems LLC.                                                               Founded in 1984 and based in Akron, Ohio, DRB Systems is the leading provider of turnkey technology solutions used to enhance the operational efficiency of car wash sites across the U.S.  DRB's integrated technology offering includes hardware and software used in point-of-sale and tunnel control systems as well as ancillary modules to support marketing, human resources, and business analytics. "New Mountain Capital is pleased to have completed its investment in DRB Systems," said Jack Qian, Director of New Mountain Capital. Laura Holson, Head of Capital Markets at New Mountain added, "We deeply value Barings' support as a financing pa

Crown Bioscience to Showcase Scientific Expertise in Preclinical Evaluation of Investigational Cancer Compounds17.10.2017 16:12Pressemelding

SANTA CLARA, Calif., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, will showcase their scientific expertise at this year's American Association for Cancer Research's International Conference on Molecular Targets and Cancer Therapeutics (AACR-NCI-EORTC) October 26th through the 30th. CrownBio's scientists will present 13 scientific posters describing their latest research efforts, including generation of novel models for combinatory chemotherapy and immunotherapy studies, creation of 3D screening panels for improved efficacy assessments, demonstration of a checkpoint immunotherapy modulating intestinal microbiota, among other innovative developments in cancer therapeutics and preclinical pharmacology evaluation. On

Oxford Immunotec Schedules Third Quarter 2017 Earnings Release and Conference Call for October 31, 201717.10.2017 15:15Pressemelding

OXFORD, United Kingdom and MARLBOROUGH, Mass., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced that it plans to release third quarter 2017 financial results prior to market open on Tuesday, October 31, 2017.  Dr. Peter Wrighton-Smith, Chief Executive Officer, and Rick Altieri, Chief Financial Officer, will host a conference call to review the Company's results at 8:00 a.m. Eastern Time the same day. The call will be concurrently webcast. To listen to the conference call on your telephone, please dial (855) 363-5047 for United States callers and +1 (484) 365-2897 for international callers and reference confirmation code 99539511, approximately ten minutes prior to start time.  To access the live audio webcast or subsequent archived recording, visit the Investor Relations se

World Conference on Lung Cancer Tuesday Press Conference: Evidence to Support Innovative Lung Cancer Interventions17.10.2017 08:16Pressemelding

YOKOHAMA, Japan, Oct. 17, 2017 (GLOBE NEWSWIRE) -- Today's press conference at the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC) featured groundbreaking findings in the study of both small cell and non-small cell lung cancer. The studies presented covered broad research areas, from confirmation of existing classification criteria to ensuring viability of evidence to supporting the use of specific interventions. Biopsy specimen found to be reliable for evaluating DLL3 expression in small cell lung cancer Small cell lung cancer (SCLC) biopsy specimen was found to be reliable material for evaluating DLL3 expression; high levels of DLL3 in SCLC are correlated with poor survival trends. These results may lead to further evaluation of the scoring system for predicting DLL3-targeted therapeutic efficacy and clinical significance of DLL3 expression in high-grade pulmonary neuroendocrine carcinomas.

New Era Launches Direct-to-Consumer eCommerce Site Built by EPAM and Powered with SAP Hybris17.10.2017 06:01Pressemelding

New Site Expands Headwear and Apparel Offering with Immersive, Omnichannel Experience NEWTOWN, Pa., Oct.  17, 2017  (GLOBE NEWSWIRE) -- EPAM Systems, Inc. (NYSE:EPAM), a leading global provider of digital platform engineering and software development services, and New Era, a global headwear brand rooted in sports, today announced the launch of New Era's first direct-to-consumer website, neweracap.com. New Era's B2B business remains strong, and the company is now putting an emphasis on selling its products directly to customers and expanding its offering into the lifestyle market. The new site offers products for seasoned athletes and sports fans, as well as street and lifestyle consumers. "In an age where businesses cannot tolerate lengthy, scope changing technology projects, EPAM quickly established themselves as the standout partner for us to tackle this ambitious initiative," said Lorenz Gan, Global Vice President, Information Technology, New Era. "Whilst this p

CP Kelco Appoints Didier Viala as New President16.10.2017 15:00Pressemelding

ATLANTA, Oct. 16, 2017 (GLOBE NEWSWIRE) -- CP Kelco, a leading global producer of specialty hydrocolloid solutions, announced today that Didier Viala has been appointed President, effective October 1, 2017. Viala replaces Donald Rubright, who served as CP Kelco President since 2006 and will retire at the end of 2017. Viala has also joined the CP Kelco Board of Directors. "As a market leader supplying high-quality hydrocolloid products for a range of foods and beverages, consumer products and industrial applications, CP Kelco will continue to invest in capacity additions, new product and applications development, strategic raw material sourcing, quality and safety management, and sustainability initiatives to support our customers' innovation efforts and growth strategies," Viala said. Over the course of more than 25 years with CP Kelco and its predecessor companies, Viala held leadership roles across a broad spectrum of critical areas, including innovat

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom